GB9201023D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB9201023D0
GB9201023D0 GB929201023A GB9201023A GB9201023D0 GB 9201023 D0 GB9201023 D0 GB 9201023D0 GB 929201023 A GB929201023 A GB 929201023A GB 9201023 A GB9201023 A GB 9201023A GB 9201023 D0 GB9201023 D0 GB 9201023D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929201023A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB929201023A priority Critical patent/GB9201023D0/en
Publication of GB9201023D0 publication Critical patent/GB9201023D0/en
Priority to EP93902402A priority patent/EP0623147A1/en
Priority to PCT/GB1993/000102 priority patent/WO1993014126A1/en
Priority to AU33596/93A priority patent/AU3359693A/en
Priority to JP5512301A priority patent/JPH07505613A/en
Priority to CA002128211A priority patent/CA2128211A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB929201023A 1992-01-17 1992-01-17 Vaccines Pending GB9201023D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB929201023A GB9201023D0 (en) 1992-01-17 1992-01-17 Vaccines
EP93902402A EP0623147A1 (en) 1992-01-17 1993-01-18 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus
PCT/GB1993/000102 WO1993014126A1 (en) 1992-01-17 1993-01-18 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus
AU33596/93A AU3359693A (en) 1992-01-17 1993-01-18 A major histocompatibility complex class II antigen in a vaccine against an immunodeficiency virus
JP5512301A JPH07505613A (en) 1992-01-17 1993-01-18 Major histocompatibility complex class 2 antigen as a vaccine against immunodeficiency virus
CA002128211A CA2128211A1 (en) 1992-01-17 1993-01-18 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929201023A GB9201023D0 (en) 1992-01-17 1992-01-17 Vaccines

Publications (1)

Publication Number Publication Date
GB9201023D0 true GB9201023D0 (en) 1992-03-11

Family

ID=10708778

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929201023A Pending GB9201023D0 (en) 1992-01-17 1992-01-17 Vaccines

Country Status (6)

Country Link
EP (1) EP0623147A1 (en)
JP (1) JPH07505613A (en)
AU (1) AU3359693A (en)
CA (1) CA2128211A1 (en)
GB (1) GB9201023D0 (en)
WO (1) WO1993014126A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274592B (en) * 1994-08-05 1997-07-18 Angela Turiano PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING XENOANTIGENS
US6168787B1 (en) * 1995-04-24 2001-01-02 John Wayne Cancer Institute Pluripotent vaccine against enveloped viruses
FR2735984B1 (en) * 1995-06-30 1997-09-19 Inst Nat Sante Rech Med VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND DIAGNOSTIC METHOD
CA2250814A1 (en) * 1996-04-03 1997-10-09 Anergen, Inc. Cyclic peptide vaccines for treatment and prevention of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591227B1 (en) * 1985-12-06 1988-11-10 Pasteur Institut PEPTIDES CAPABLE OF INHIBITING INTERACTIONS BETWEEN LAV VIRUSES AND T4 LYMPHOCYTES, DERIVATIVES THEREOF AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
EP0623147A1 (en) 1994-11-09
CA2128211A1 (en) 1993-07-22
AU3359693A (en) 1993-08-03
WO1993014126A1 (en) 1993-07-22
JPH07505613A (en) 1995-06-22

Similar Documents

Publication Publication Date Title
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
ZA947828B (en) Vaccines
GB9106048D0 (en) Vaccines
GB9325496D0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9202933D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9322702D0 (en) Vaccines
ZA948729B (en) Vaccines
GB9226768D0 (en) Vaccines
ZA933541B (en) Vaccines
GB9220360D0 (en) Vaccines
GB9216317D0 (en) Vaccines
GB9221891D0 (en) Vaccines
GB9226283D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9217635D0 (en) Vaccines
GB9218833D0 (en) Vaccines
GB9211318D0 (en) Vaccines
GB9206788D0 (en) Vaccine
GB9307028D0 (en) Vaccine
GB9206786D0 (en) Vaccine